For research use only. Not for therapeutic Use.
Tetranor-PGAM (Tetranor-Prostaglandin A Metabolite) (CAT: R064451) is a stable metabolite of prostaglandin A, playing a crucial role in the regulation of inflammation and immune responses. It is widely used as a biomarker to assess prostaglandin metabolism in clinical and biomedical research. Elevated levels of tetranor-PGAM in urine or plasma can indicate enhanced prostaglandin activity, often associated with inflammatory conditions, cardiovascular diseases, or cancer. Its measurement helps researchers and clinicians monitor disease progression and the efficacy of anti-inflammatory therapies. Due to its stability and specificity, Tetranor-PGAM is essential in understanding the metabolic pathways involved in inflammatory processes.
Catalog Number | R064451 |
CAS Number | 52510-53-9 |
Synonyms | tetranor-Prostaglandin A Metabolite |
Molecular Formula | C16H22O6 |
Purity | ≥95% |
Target | Drug Metabolite |
Storage | -80°C |
IUPAC Name | 8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid |
InChI | InChI=1S/C16H22O6/c17-12(3-1-2-4-15(19)20)7-5-11-6-9-14(18)13(11)8-10-16(21)22/h6,9,11,13H,1-5,7-8,10H2,(H,19,20)(H,21,22)/t11-,13+/m0/s1 |
InChIKey | HYPIFMOQVFWSBF-WCQYABFASA-N |
SMILES | C1=CC(=O)C(C1CCC(=O)CCCCC(=O)O)CCC(=O)O |